Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults

ClinicalTrials.gov ID: NCT02142504

Public ClinicalTrials.gov record NCT02142504. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 5:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II, Randomized, Placebo-controlled, Double-blind, Safety and Immunogenicity Trial of Intramuscular Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in Healthy Adults

Study identification

NCT ID
NCT02142504
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Takeda
Industry
Enrollment
454 participants

Conditions and interventions

Interventions

  • Norovirus Bivalent VLP Vaccine Biological
  • Placebo (Saline) Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 49 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 14, 2014
Primary completion
Jan 5, 2016
Completion
Jan 5, 2016
Last update posted
Aug 20, 2017

2014 – 2016

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
California Research Foundation San Diego California 92103-6204
Benchmark Research San Francisco San Francisco California 94108
Clin Research of South Florida Coral Gables Florida 33134
SNBL Baltimore Maryland 21201
St. Louis University, School of Medicine St Louis Missouri 63104
Rochester Clinical Research Rochester New York 14609
University of Rochester Rochester New York 14642
Cincinnati Childrens Hospital Medical Center Cincinnati Ohio 45206
Benchmark Research Austin Austin Texas 78705
Baylor College of Medicine Houston Texas 77030-3498

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02142504, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2017 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02142504 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →